Skip to main content
Log in

Non-invasive Prenatal Diagnosis for BRCA Mutations – a Qualitative Pilot Study of Health Professionals’ Views

  • Original Research
  • Published:
Journal of Genetic Counseling

Abstract

Non-invasive prenatal diagnosis (NIPD) is a rapidly advancing approach that allows diagnostic testing based on analysis of cell free DNA in maternal plasma. This study aimed to explore the views of health professionals regarding the use of NIPD for BRCA1/2 mutations. Qualitative semi-structured interviews were conducted with eight participants. Whilst participants viewed NIPD in general as a positive step forward in prenatal testing, they were cautious about its use for BRCA testing. Significant ethical concerns emerged regarding testing prenatally for an adult onset condition, that is not fully penetrant, and the possibility of abrogating the rights of the future child to genetic autonomy. Nevertheless, participants did identify some situations whereby the test might be beneficial, such as for individuals with very negative and traumatic personal experiences of cancer desiring reassurance or wanting to prevent passing on the condition. NIPD was also seen as having benefits over invasive testing and pre-implantation genetic diagnosis, the only other options currently available to test prenatally for this condition. Exploring the views of a wider range of clinical specialties as well as patients at risk of hereditary breast cancer would be beneficial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • American College of Obstetricians and Gynecologists Committee on Genetics. (2012). Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstetrics and Gynecology, 120, 1532–1534.

    Article  Google Scholar 

  • Barrett, A. N., McDonnell, T. C., Chan, K. C., & Chitty, L. S. (2012). Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clinical Chemistry, 58, 1026–1032.

    Article  CAS  PubMed  Google Scholar 

  • Bianchi, D. W., Platt, L. D., Goldberg, J. D., Abuhamad, A. Z., Sehnert, A. J., & Rava, R. P. (2012). Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics and Gynecology, 119, 890–901.

    Article  CAS  PubMed  Google Scholar 

  • Borry, P., Fryns, J. P., Schotsmans, P., & Dierickx, K. (2006a). Carrier testing in minors: a systematic review of guidelines and position papers. European Journal of Human Genetics, 14, 133–138.

    Article  PubMed  Google Scholar 

  • Borry, P., Stultiens, L., Nys, H., Cassiman, J. J., & Dierickx, K. (2006b). Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clinical Genetics, 70, 374–381.

    Article  CAS  PubMed  Google Scholar 

  • Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3, 77–101.

    Article  Google Scholar 

  • Chitty, L. S., Griffin, D. R., Meaney, C., Barrett, A., Khalil, A., Pajkrt, E., et al. (2011). New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma. Ultrasound in Obstetrics and Gynecology, 37, 283–289.

    Article  CAS  PubMed  Google Scholar 

  • de Jong, A., Dondorp, W. J., de Die-Smulders, C. E., Frints, S. G., & de Wert, G. M. (2010). Non-invasive prenatal testing: ethical issues explored. European Journal of Human Genetics, 18, 272–277.

    Article  PubMed Central  PubMed  Google Scholar 

  • Derks-Smeets, I. A., Gietel-Habets, J. J., Tibben, A., Tjan-Heijnen, V. C., Meijer-Hoogeveen, M., Geraedts, J. P., et al. (2014). Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer. Human Reproduction, 29, 1103–1112.

    Article  CAS  PubMed  Google Scholar 

  • Donnelly, L. S., Watson, M., Moynihan, C., Bancroft, E., Evans, D. G., Eeles, R., et al. (2013). Reproductive decision-making in young female carriers of a BRCA mutation. Human Reproduction, 28, 1006–1012.

    Article  CAS  PubMed  Google Scholar 

  • Finning, K. M., & Chitty, L. S. (2008). Non-invasive fetal sex determination: impact on clinical practice. Seminars in Fetal and Neonatal Medicine, 13, 69–75.

    Article  PubMed  Google Scholar 

  • Fortuny, D., Balmana, J., Grana, B., Torres, A., Ramon y Cajal, T., Darder, E., et al. (2009). Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort. Human Reproduction, 24, 1000–1006.

    Article  PubMed  Google Scholar 

  • Fossey, E., Harvey, C., McDermott, F., & Davidson, L. (2002). Understanding and evaluating qualitative research. The Australian and New Zealand Journal of Psychiatry, 36, 717–732.

    Article  PubMed  Google Scholar 

  • Hill, M., Karunaratna, M., Lewis, C., Forya, F., & Chitty, L. (2013). Views and preferences for the implementation of non-invasive prenatal diagnosis for single gene disorders from health professionals in the United Kingdom. American Journal of Medical Genetics Part A, 161A, 1612–1618.

    Article  PubMed  Google Scholar 

  • Illanes, S., Denbow, M., Kailasam, C., Finning, K., & Soothill, P. W. (2007). Early detection of cell-free fetal DNA in maternal plasma. Early Human Development, 83, 563–566.

    Article  CAS  PubMed  Google Scholar 

  • Julian-Reynier, C., Fabre, R., Coupier, I., Stoppa-Lyonnet, D., Lasset, C., Caron, O., et al. (2012). BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis. Genetics in Medicine, 14, 527–534.

    Article  PubMed Central  PubMed  Google Scholar 

  • Kelly, S. E., & Farrimond, H. R. (2012). Non-invasive prenatal genetic testing: a study of public attitudes. Public Health Genomics, 15, 73–81.

    Article  CAS  PubMed  Google Scholar 

  • Lewis, C., Hill, M., Skirton, H., & Chitty, L. (2012). Non-invasive prenatal diagnosis for fetal sex determination – benefits and disadvantages from the service users’ perspective. European Journal of Human Genetics, 20, 1127–1133.

    Article  PubMed Central  PubMed  Google Scholar 

  • Lewis, C., Silcock, C., & Chitty, L. S. (2013). Non-invasive prenatal testing for Down’s syndrome – pregnant women’s views and likely uptake. Public Health Genomics, 16, 223–232.

    Article  CAS  PubMed  Google Scholar 

  • Lewis, C., Hill, M., & Chitty, L. (2014a). Non-invasive prenatal diagnosis for single gene disorders: experience of patients. Clinical Genetics, 85, 336–342.

    Article  CAS  PubMed  Google Scholar 

  • Lewis, C., Hill, M., Silcock, C., Daley, R., & Chitty, L. S. (2014b). Non-invasive prenatal testing for trisomy 21: a cross sectional survey of service users’ views and likely uptake. BJOG, 121, 582–594.

    Article  CAS  PubMed  Google Scholar 

  • Lo, Y. M., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., et al. (1997). Presence of fetal DNA in maternal plasma and serum. Lancet, 350, 485–487.

    Article  CAS  PubMed  Google Scholar 

  • McAllister, M., Payne, K., Macleod, R., Nicholls, S., Dian, D., & Davies, L. (2008). Patient empowerment in clinical genetics services. Journal of Health Psychology, 13, 895–905.

    Article  PubMed  Google Scholar 

  • Nelson, H. D., Huffman, L. H., Fu, R., & Harris, E. L. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 143, 362–379.

    Article  CAS  PubMed  Google Scholar 

  • Ormondroyd, E., Donnelly, L., Moynihan, C., Savona, C., Bancroft, E., Evans, D. G., et al. (2012). Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis. European Journal of Human Genetics, 20, 4–10.

  • Palomaki, G. E., Deciu, C., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., et al. (2012). DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genetics in Medicine, 14, 296–305.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Skirton, H., Goldsmith, L., Jackson, L., & Tibben, A. (2013). Quality in genetic counselling for presymptomatic testing--clinical guidelines for practice across the range of genetic conditions. European Journal of Human Genetics, 21, 256–260.

    Article  PubMed Central  PubMed  Google Scholar 

  • Tabor, A., & Alfirevic, Z. (2010). Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagnosis and Therapy, 27, 1–7.

    Article  PubMed  Google Scholar 

  • Tischler, R., Hudgins, L., Blumenfeld, Y. J., Greely, H. T., & Ormond, K. E. (2011). Noninvasive prenatal diagnosis: pregnant women’s interest and expected uptake. Prenatal Diagnosis, 31, 1292–1299.

    Article  PubMed Central  PubMed  Google Scholar 

  • Tsui, N. B., Kadir, R. A., Chan, K. C., Chi, C., Mellars, G., Tuddenham, E. G., et al. (2011). Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood, 117, 3684–3691.

    Article  CAS  PubMed  Google Scholar 

  • van den Heuvel, A., Chitty, L., Dormandy, E., Newson, A., Deans, Z., Attwood, S., et al. (2009). Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Education and Counseling, 78, 24–28.

    Article  PubMed  Google Scholar 

  • Wagner, T. M., & Ahner, R. (1998). Prenatal testing for late-onset diseases such as mutations in the breast cancer gene 1 (BRCA1). Just a choice or a step in the wrong direction? Human Reproduction, 13, 1125–1126.

    Article  CAS  PubMed  Google Scholar 

  • Willig, C. (2008). Introducing qualitative research methods in psychology qualitative research design (pp. 15–32). Maidenhead: McGraw Hill.

    Google Scholar 

  • Yi, H., Hallowell, N., Griffiths, S., & Yeung Leung, T. (2013). Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong. PLoS One, 8, e81794.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge and thank all the health professionals who took part in this study and the reviewers of this paper for their insightful comments.

Conflict of Interest

The authors Jade Bennett, Lyn Chitty and Celine Lewis declare that they have no conflict of interest.

Human Studies and Informed Consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study. No animal studies were carried out by the authors for this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Celine Lewis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bennett, J., Chitty, L. & Lewis, C. Non-invasive Prenatal Diagnosis for BRCA Mutations – a Qualitative Pilot Study of Health Professionals’ Views. J Genet Counsel 25, 198–207 (2016). https://doi.org/10.1007/s10897-015-9858-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10897-015-9858-0

Keywords

Navigation